[(89)Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer

PURPOSE: To evaluate safety, human radiation dosimetry and optimal imaging time of [(89)Zr]trastuzumab in patients with HER2-positive breast cancer. PROCEDURES: Twelve women with HER2-positive breast cancer underwent [(89)Zr]trastuzumab-PET/CT twice within 7 days postinjection. Biodistribution data...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Imaging Biol
Main Authors: Laforest, Richard, Lapi, Suzanne E., Oyama, Reiko, Bose, Ron, Tabchy, Adel, Marquez-Nostra, Bernadette V., Burkemper, Jennifer, Wright, Brian D., Frye, Jennifer, Frye, Sarah, Siegel, Barry A., Dehdashti, Farrokh
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5096950/
https://ncbi.nlm.nih.gov/pubmed/27146421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11307-016-0951-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados